Melatonin — Expert Claims
Extracted from publicly available podcast transcripts and videos. Each claim is attributed and sourced.
Claims are extracted using AI (Claude) from publicly available transcripts and manually reviewed. Extraction confidence (high / medium / low) indicates accuracy of capture. Each claim is compared against PubMed research.
3 expert mentions
"I want to be very clear about melatonin: most people are taking way too much. The doses in the pharmacy are 5, 10 milligrams — these are enormously supraphysiological. The actual amount your brain produces is probably in the range of 0.1 to 0.3 milligrams. If you're going to use melatonin, a dose of 0.5 milligrams is probably closer to what you want."
Most people take far too much melatonin. Commercial doses of 5-10mg are supraphysiological — the physiological range is closer to 0.1-0.5mg, and lower doses are likely more effective and associated with fewer next-day side effects.
Huberman's claim about supraphysiological commercial doses is well-supported. Endogenous nocturnal melatonin peaks are typically in the range of 100-200 pg/mL, and even low-dose supplementation (0.1-0.3mg) can produce serum levels that far exceed this. Research by Auger et al. and others supports that 0.5mg can produce circadian phase shifts comparable to higher doses with less residual sedation. This is one of Huberman's more evidence-aligned supplement claims.
"When it comes to melatonin, I always ask: what are you actually trying to do? If you're crossing time zones, the evidence is pretty good — it helps reset your clock. But if you're a healthy person who just wants better sleep, the data is less clear. And timing matters enormously — you can actually delay your sleep phase if you take it at the wrong time of day."
The strongest evidence for melatonin is in jet lag and shift work — contexts where circadian rhythm is genuinely disrupted. Using it for general sleep improvement in healthy adults without circadian disruption has weaker support, and the timing of the dose is as important as the dose itself.
Marks accurately stratifies the evidence by use case. Jet lag evidence (Brzezinski et al. systematic review) is among the most consistent in the melatonin literature. Evidence for general sleep improvement in healthy adults is modest (small effect sizes in meta-analyses). Her caution about timing-dependent phase shifting is clinically accurate — melatonin taken in the morning can advance circadian phase in the wrong direction. This is a careful, evidence-calibrated representation.
"Melatonin is often misunderstood. People take it thinking it will knock them out or improve their deep sleep — but that's not really how it works. It's a circadian signal. It says, "it's time to sleep," but it doesn't particularly improve the quality of sleep once you're there. If you're using it for jet lag or shift work, that's where the evidence is strongest."
Melatonin is primarily a circadian timing signal, not a sleep-depth enhancer. It tells the brain when to sleep but does not meaningfully improve deep sleep or sleep architecture in the way that other interventions (e.g., behavioral or pharmacological) do.
Attia's framing is accurate and well-supported by the literature. Meta-analyses (Ferracioli-Oda et al., 2013) show modest reductions in sleep onset latency but minimal effects on slow-wave or REM sleep architecture. The strongest evidence is for circadian rhythm disorders (jet lag, shift work, delayed sleep phase) rather than general sleep quality improvement in healthy adults. This represents an accurate and appropriately nuanced characterization of the melatonin evidence.